XML 26 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)
$ in Thousands
Dec. 31, 2015
Dec. 31, 2014
Current assets    
Cash and cash equivalents $ 204,586 $ 237,375
Accounts receivable, less allowance for doubtful accounts of $695 and $476 101,428 99,065
Inventories 91,824 76,806 [1]
Prepaid income taxes 5,058 4,586
Deferred income taxes 9,565 6,467
Asbestos-related insurance receivables 8,245 6,827
Other current assets 8,431 7,048
Total current assets 429,137 438,174
Property, plant and equipment, net of accumulated depreciation 178,661 150,420
Investments in unconsolidated joint ventures 15,348 17,214
Deferred income taxes 8,594 44,051
Goodwill 175,453 98,227
Other intangible assets 75,019 38,340
Asbestos-related insurance receivables 45,114 46,186
Other long-term assets 5,132 7,823
Total assets 932,458 840,435
Current liabilities    
Accounts payable 19,851 20,020
Accrued employee benefits and compensation 23,263 33,983
Accrued income taxes payable 3,599 6,103
Current portion of lease obligation 284 747
Current portion of long term debt 3,438 35,000
Asbestos-related liabilities 8,245 6,827
Other accrued liabilities 20,440 17,765
Total current liabilities 79,120 120,445
Long term debt 175,188 25,000
Long term lease obligation 5,549 6,042
Pension liability 12,623 17,652
Retiree health care and life insurance benefits 2,185 8,768
Asbestos-related liabilities 48,390 49,718
Non-current income tax 11,863 10,544
Deferred income taxes 9,455 14,647
Other long-term liabilities $ 3,503 $ 338
Commitments and Contingencies (Note 15)
Shareholders’ Equity    
Capital Stock - $1 par value; 50,000 authorized shares; 17,957 and 18,404 shares outstanding $ 17,957 $ 18,404
Additional paid-in capital 112,017 137,225
Retained earnings 543,066 496,746
Accumulated other comprehensive loss (88,458) (65,094)
Total shareholders' equity 584,582 587,281
Total liabilities and shareholders' equity $ 932,458 $ 840,435
[1] Inventory amounts have been adjusted for the 2015 conversion from LIFO to FIFO as discussed above.